<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Elisence – Phase 1: GLP-1 & Metabolic Intelligence Core</title>

    <style>
        body {
            margin: 0;
            font-family: Arial, Helvetica, sans-serif;
            background-color: #08172a;
            color: #e8f4fc;
            line-height: 1.6;
        }

        /* ======= HEADER ======= */
        header {
            background-color: #020617;
            padding: 1.8rem 0;
            border-bottom: 1px solid #1e293b;
            box-shadow: 0 6px 20px rgba(0, 0, 0, 0.6);
        }

        .header-inner {
            max-width: 1100px;
            margin: 0 auto;
            padding: 0 1.5rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .brand-block {
            display: flex;
            flex-direction: column;
        }

        .brand-title {
            font-size: 1.4rem;
            font-weight: 700;
            letter-spacing: 0.14rem;
        }

        .brand-sub {
            font-size: 0.85rem;
            color: #60a5fa;
        }

        nav.main-nav {
            display: flex;
            gap: 1.8rem;
        }

        nav.main-nav a {
            color: #e2e8f0;
            text-decoration: none;
            font-size: 0.92rem;
            letter-spacing: 0.05rem;
            text-transform: uppercase;
        }

        nav.main-nav a:hover {
            color: #38bdf8;
            text-decoration: underline;
        }

        nav.main-nav a.active {
            color: #38bdf8;
            font-weight: 600;
        }

        /* ======= MAIN CONTENT ======= */
        main {
            max-width: 1100px;
            margin: 2.4rem auto 3.2rem auto;
            padding: 0 1.5rem;
        }

        h1 {
            font-size: 1.9rem;
            margin-bottom: 0.6rem;
            color: #38bdf8;
        }

        .lead {
            font-size: 1rem;
            color: #cbd5f5;
            margin-bottom: 1.8rem;
        }

        .card {
            background: rgba(15, 23, 42, 0.95);
            border-radius: 18px;
            border: 1px solid #1e293b;
            box-shadow: 0 16px 50px rgba(0, 0, 0, 0.55);
            padding: 1.8rem 1.9rem;
            margin-bottom: 1.8rem;
        }

        .card h2 {
            margin-top: 0;
            margin-bottom: 0.8rem;
            font-size: 1.3rem;
            color: #7dd3fc;
        }

        .card p {
            margin: 0.4rem 0;
            font-size: 0.95rem;
            color: #e5f2ff;
        }

        .card ul {
            margin: 0.5rem 0 0.2rem 1.2rem;
            padding-left: 0.4rem;
        }

        .card li {
            margin-bottom: 0.4rem;
            font-size: 0.94rem;
        }

        .tagline {
            font-size: 0.95rem;
            color: #93c5fd;
            margin-bottom: 0.5rem;
        }

        .phase-label {
            font-size: 0.82rem;
            text-transform: uppercase;
            letter-spacing: 0.12rem;
            color: #94a3b8;
            margin-bottom: 0.4rem;
        }

        /* ======= RESPONSIVE ======= */
        @media (max-width: 900px) {
            .header-inner {
                flex-direction: column;
                align-items: flex-start;
                gap: 0.8rem;
            }

            nav.main-nav {
                flex-wrap: wrap;
                gap: 1.1rem;
            }

            main {
                padding: 0 1.2rem;
            }

            .card {
                padding: 1.5rem 1.4rem;
            }
        }
    </style>
</head>
<body>

<header>
    <div class="header-inner">
        <div class="logo-section">
            <img src="elisence.png" alt="Elisence Logo" class="logo-img">
            <div class="logo-text">
                <h1>ELISENCE</h1>
                <p>Global Digital Health & Humanity Platform</p>
            </div>
        </div>

        <nav class="main-nav">
            <a href="index.html">Home</a>
            <a href="index.html#phases">Phases</a>
            <a href="about.html">About</a>
            <a href="story.html">Story</a>
            <a href="video.html">Videos</a>
            <a href="contact.html">Contact</a>
        </nav>
    </div>
</header>

<main>
    <div class="phase-label">PHASE 1</div>
    <h1>GLP-1 & Metabolic Intelligence Core</h1>
    <p class="lead">
        Phase 1 is the GLP-1 and weight / metabolic intelligence foundation of Elisence – the place where
        real-world data about weight, medication, side effects, behaviour, and habits is transformed into
        safe, non-diagnostic insights for users, clinicians, and future national programmes.
    </p>

    <section class="card">
        <h2>What Phase 1 Does</h2>
        <p class="tagline">
            From numbers on a scale to a clear, structured picture of metabolic health.
        </p>
        <p>
            Phase 1 collects and organises core metabolic signals, including:
        </p>
        <ul>
            <li>Weight trends and body-mass changes over time</li>
            <li>GLP-1 and related medication doses (e.g. Ozempic, Mounjaro, Wegovy)</li>
            <li>Side effects, benefits, and day-to-day symptoms</li>
            <li>Sleep, appetite, energy patterns and lifestyle behaviours</li>
            <li>Key context such as timing, adherence, and basic routines</li>
        </ul>
        <p>
            The goal of Phase 1 is simple: build a clean, structured metabolic “timeline” for each user –
            something clear enough for a person to understand, and precise enough that a clinician or
            ministry could later use it safely as part of a wider system.
        </p>
    </section>

    <section class="card">
        <h2>How It Works for Users</h2>
        <p>
            For individuals and families, Phase 1 feels like a calm, organised, GLP-1 companion
            rather than a spreadsheet of numbers.
        </p>
        <ul>
            <li>Simple daily or weekly check-ins instead of long forms</li>
            <li>Clear trends (e.g. “your weight is stabilising”, “side effects are decreasing”)</li>
            <li>Gentle alerts if something looks unusual or worth discussing with a doctor</li>
            <li>Support from <strong>Elisa</strong>, who translates data into plain, human language</li>
        </ul>
        <p>
            Phase 1 never tells people what dose to take, never replaces clinical advice,
            and never acts as a prescriber. It simply organises and explains.
        </p>
    </section>

    <section class="card">
        <h2>How It Supports Clinicians & Clinics</h2>
        <p>
            For doctors, nurses and clinics, Phase 1 is designed to become a structured “GLP-1 & metabolic
            snapshot” that answers questions quickly:
        </p>
        <ul>
            <li>What has actually happened to weight since starting GLP-1 therapy?</li>
            <li>What side effects appeared, when, and in what context?</li>
            <li>How stable are the user’s routines, sleep and energy levels?</li>
            <li>Is the overall pattern improving, plateauing, or concerning?</li>
        </ul>
        <p>
            This allows clinicians to spend less time trying to reconstruct history,
            and more time making safe, human decisions together with the patient.
        </p>
    </section>

    <section class="card">
        <h2>Governance & Safety Principles</h2>
        <p>
            Phase 1 follows the same safety philosophy as the rest of Elisence:
        </p>
        <ul>
            <li><strong>Non-diagnostic:</strong> it never labels, diagnoses, or prescribes.</li>
            <li><strong>Explain, not decide:</strong> it helps people understand patterns, not replace doctors.</li>
            <li><strong>Zero-trust security:</strong> all data is treated as sensitive by default.</li>
            <li><strong>Clinical-ready structure:</strong> the data can later feed phases 4 and 8 for national use.</li>
        </ul>
        <p>
            The outputs of Phase 1 are designed to plug directly into future
            <strong>Phase 4 (Governance & Infrastructure)</strong> and
            <strong>Phase 8 (Advanced Health Engine)</strong> when ministries or hospitals want to scale.
        </p>
    </section>

    <section class="card">
        <h2>Role Inside the 17-Phase Roadmap</h2>
        <p>
            Phase 1 is the metabolic foundation of Elisence. It connects directly to:
        </p>
        <ul>
            <li><strong>Phase 2 & 3:</strong> medication choice, daily care and weight-loss coaching</li>
            <li><strong>Phase 7:</strong> women’s health and hormone-linked metabolic changes</li>
            <li><strong>Phase 8:</strong> blood markers, risk engines, emergency-related patterns</li>
            <li><strong>Phase 9:</strong> full diabetes and long-term metabolic health</li>
            <li><strong>Phase 16:</strong> nutrition & GNIE – personal diet and environment-aware guidance</li>
        </ul>
        <p>
            By starting from Phase 1, Elisence builds a stable, trustworthy base that can grow safely
            into a national-scale health intelligence and support system.
        </p>
    </section>
</main>

</body>
</html>
